Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 24 studies | 27% ± 11% | |
| macrophage | 15 studies | 32% ± 15% | |
| microglial cell | 14 studies | 38% ± 14% | |
| fibroblast | 12 studies | 28% ± 9% | |
| oligodendrocyte | 12 studies | 36% ± 14% | |
| astrocyte | 11 studies | 34% ± 19% | |
| GABAergic neuron | 10 studies | 36% ± 24% | |
| B cell | 10 studies | 23% ± 5% | |
| natural killer cell | 9 studies | 19% ± 3% | |
| glutamatergic neuron | 9 studies | 42% ± 27% | |
| oligodendrocyte precursor cell | 9 studies | 27% ± 10% | |
| epithelial cell | 9 studies | 32% ± 16% | |
| adipocyte | 9 studies | 31% ± 7% | |
| mast cell | 8 studies | 27% ± 9% | |
| myeloid cell | 8 studies | 32% ± 13% | |
| retinal ganglion cell | 7 studies | 36% ± 21% | |
| pericyte | 7 studies | 23% ± 8% | |
| smooth muscle cell | 7 studies | 23% ± 5% | |
| CD4-positive, alpha-beta T cell | 6 studies | 18% ± 1% | |
| neuron | 6 studies | 36% ± 19% | |
| interneuron | 6 studies | 43% ± 25% | |
| amacrine cell | 6 studies | 31% ± 9% | |
| retina horizontal cell | 6 studies | 26% ± 8% | |
| retinal rod cell | 6 studies | 25% ± 7% | |
| monocyte | 6 studies | 32% ± 7% | |
| CD8-positive, alpha-beta T cell | 6 studies | 18% ± 1% | |
| dendritic cell | 6 studies | 33% ± 5% | |
| endothelial cell of lymphatic vessel | 6 studies | 30% ± 7% | |
| type II pneumocyte | 6 studies | 20% ± 3% | |
| plasmacytoid dendritic cell | 6 studies | 20% ± 8% | |
| non-classical monocyte | 5 studies | 24% ± 5% | |
| capillary endothelial cell | 5 studies | 17% ± 1% | |
| retinal bipolar neuron | 5 studies | 26% ± 5% | |
| ciliated cell | 5 studies | 25% ± 6% | |
| Mueller cell | 5 studies | 25% ± 10% | |
| abnormal cell | 5 studies | 24% ± 12% | |
| T cell | 5 studies | 21% ± 4% | |
| type I pneumocyte | 5 studies | 23% ± 5% | |
| goblet cell | 5 studies | 30% ± 18% | |
| basal cell | 5 studies | 34% ± 19% | |
| effector memory CD8-positive, alpha-beta T cell | 4 studies | 19% ± 1% | |
| granule cell | 4 studies | 24% ± 4% | |
| retinal cone cell | 4 studies | 25% ± 3% | |
| lymphocyte | 4 studies | 29% ± 9% | |
| OFF-bipolar cell | 4 studies | 28% ± 8% | |
| ON-bipolar cell | 4 studies | 30% ± 9% | |
| club cell | 4 studies | 22% ± 6% | |
| classical monocyte | 3 studies | 21% ± 5% | |
| conventional dendritic cell | 3 studies | 29% ± 13% | |
| hematopoietic precursor cell | 3 studies | 31% ± 12% | |
| naive thymus-derived CD4-positive, alpha-beta T cell | 3 studies | 17% ± 1% | |
| GABAergic interneuron | 3 studies | 25% ± 4% | |
| glial cell | 3 studies | 23% ± 4% | |
| precursor B cell | 3 studies | 22% ± 4% | |
| myofibroblast cell | 3 studies | 22% ± 5% | |
| plasma cell | 3 studies | 34% ± 6% | |
| pro-B cell | 3 studies | 24% ± 4% | |
| cardiac muscle cell | 3 studies | 17% ± 1% | |
| mesothelial cell | 3 studies | 30% ± 9% | |
| mononuclear phagocyte | 3 studies | 28% ± 9% | |
| vein endothelial cell | 3 studies | 27% ± 15% | |
| GABAergic amacrine cell | 3 studies | 27% ± 10% | |
| glycinergic amacrine cell | 3 studies | 25% ± 4% | |
| rod bipolar cell | 3 studies | 38% ± 13% | |
| hepatocyte | 3 studies | 31% ± 11% | |
| leukocyte | 3 studies | 31% ± 5% | |
| alveolar macrophage | 3 studies | 43% ± 10% | |
| transit amplifying cell | 3 studies | 45% ± 32% | |
| naive B cell | 3 studies | 19% ± 1% | |
| mucus secreting cell | 3 studies | 21% ± 4% | |
| CD8-positive, alpha-beta memory T cell | 3 studies | 16% ± 0% | |
| regulatory T cell | 3 studies | 17% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 703.40 | 1445 / 1445 | 100% | 21.98 | 183 / 183 |
| ovary | 100% | 656.50 | 180 / 180 | 100% | 16.25 | 429 / 430 |
| lung | 100% | 597.66 | 577 / 578 | 100% | 19.87 | 1152 / 1155 |
| breast | 100% | 978.31 | 459 / 459 | 100% | 18.54 | 1113 / 1118 |
| brain | 100% | 965.94 | 2637 / 2642 | 100% | 16.13 | 703 / 705 |
| stomach | 100% | 496.97 | 358 / 359 | 99% | 14.65 | 283 / 286 |
| uterus | 100% | 799.71 | 170 / 170 | 98% | 19.86 | 452 / 459 |
| intestine | 100% | 690.34 | 966 / 966 | 98% | 13.62 | 518 / 527 |
| bladder | 100% | 747.14 | 21 / 21 | 97% | 14.03 | 490 / 504 |
| prostate | 100% | 676.91 | 244 / 245 | 98% | 12.10 | 490 / 502 |
| thymus | 100% | 737.37 | 652 / 653 | 97% | 11.12 | 587 / 605 |
| pancreas | 98% | 361.60 | 320 / 328 | 98% | 9.85 | 175 / 178 |
| kidney | 100% | 571.39 | 89 / 89 | 95% | 10.86 | 856 / 901 |
| adrenal gland | 100% | 850.54 | 258 / 258 | 94% | 11.39 | 217 / 230 |
| skin | 100% | 861.02 | 1807 / 1809 | 93% | 12.97 | 438 / 472 |
| liver | 98% | 327.43 | 221 / 226 | 87% | 7.20 | 354 / 406 |
| adipose | 100% | 913.14 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1230.28 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 11.04 | 29 / 29 |
| spleen | 100% | 531.56 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 24.41 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 4.86 | 1 / 1 |
| muscle | 100% | 598.45 | 801 / 803 | 0% | 0 | 0 / 0 |
| heart | 93% | 508.15 | 799 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 85% | 538.12 | 788 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 44% | 2.52 | 35 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006913 | Biological process | nucleocytoplasmic transport |
| GO_0000398 | Biological process | mRNA splicing, via spliceosome |
| GO_0008380 | Biological process | RNA splicing |
| GO_0046677 | Biological process | response to antibiotic |
| GO_0000380 | Biological process | alternative mRNA splicing, via spliceosome |
| GO_0016607 | Cellular component | nuclear speck |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0005515 | Molecular function | protein binding |
| Gene name | RSRC1 |
| Protein name | Serine/Arginine-related protein 53 (SRrp53) (Arginine/serine-rich coiled-coil protein 1) Arginine and serine rich coiled-coil 1 |
| Synonyms | SRRP53 BM-011 |
| Description | FUNCTION: Has a role in alternative splicing and transcription regulation . Involved in both constitutive and alternative pre-mRNA splicing. May have a role in the recognition of the 3' splice site during the second step of splicing. . |
| Accessions | ENST00000611884.5 [Q96IZ7-1] ENST00000480119.5 C9JVB3 ENST00000312179.10 [Q96IZ7-2] A0A804HJI2 ENST00000683137.1 ENST00000482822.3 ENST00000477788.5 H7C558 F8WDM0 A0A804HLK3 ENST00000471994.5 A0A804HJC0 ENST00000480820.5 [Q96IZ7-1] Q96IZ7 C9J8Q2 ENST00000475278.6 ENST00000295930.7 [Q96IZ7-1] ENST00000684604.1 A0A804HIP2 C9J713 H7C5Q0 ENST00000683899.1 A0A804HK29 ENST00000476899.6 ENST00000682164.1 ENST00000464171.5 [Q96IZ7-2] C9J367 ENST00000682500.1 ENST00000682221.1 ENST00000494002.5 |